Becton, Dickinson and Company (BDX)
NYSE: BDX · Real-Time Price · USD
214.52
+1.91 (0.90%)
At close: Nov 11, 2026, 4:00 PM EST
214.01
-0.51 (-0.24%)
Pre-market: Nov 12, 2026, 5:23 AM EST
BDX Revenue
In the fiscal year ending September 30, 2026, Becton, Dickinson and Company had annual revenue of $19.46B, down -10.91%. Becton, Dickinson and Company had revenue of $5.27B in the quarter ending September 30, 2026, a decrease of -20.98%. That makes Becton, Dickinson and Company the 777th largest company in the world by revenue and 258th in the United States.
Revenue (ttm)
$19.46B
Revenue Growth
-10.91%
P/S Ratio
3.00
Revenue / Employee
$324,283
Employees
60,000
Market Cap
58.43B
Revenue by Segment
Fiscal year ended Sep 30, 2026 See the full BDX breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2026 | 19.46B | -2.38B | -10.91% |
| Sep 30, 2025 | 21.84B | 1.66B | 8.24% |
| Sep 30, 2024 | 20.18B | 806.00M | 4.16% |
| Sep 30, 2023 | 19.37B | 502.00M | 2.66% |
| Sep 30, 2022 | 18.87B | -261.00M | -1.36% |
| Sep 30, 2021 | 19.13B | 2.01B | 11.77% |
| Sep 30, 2020 | 17.12B | -173.00M | -1.00% |
| Sep 30, 2019 | 17.29B | 1.31B | 8.18% |
| Sep 30, 2018 | 15.98B | 3.89B | 32.17% |
| Sep 30, 2017 | 12.09B | -390.00M | -3.12% |
| Sep 30, 2016 | 12.48B | 2.20B | 21.41% |
| Sep 30, 2015 | 10.28B | 1.84B | 21.74% |
| Sep 30, 2014 | 8.45B | 392.00M | 4.87% |
| Sep 30, 2013 | 8.05B | 346.00M | 4.49% |
| Sep 30, 2012 | 7.71B | 124.00M | 1.64% |
| Sep 30, 2011 | 7.58B | 459.62M | 6.45% |
| Sep 30, 2010 | 7.12B | 137.66M | 1.97% |
| Sep 30, 2009 | 6.99B | 89.10M | 1.29% |
| Sep 30, 2008 | 6.90B | 614.78M | 9.79% |
| Sep 30, 2007 | 6.28B | 544.82M | 9.49% |
| Sep 30, 2006 | 5.74B | 397.18M | 7.44% |
| Sep 30, 2005 | 5.34B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Medline | 30.68B |
| Baxter International | 11.61B |
| Intuitive Surgical | 11.58B |
| Alcon | 10.86B |
| Solventum | 8.16B |
| Avantor | 6.64B |
| ResMed | 5.73B |
| The Cooper Companies | 4.24B |
BDX News
- 1 day ago - BD to Host Investor Day on December 10, 2026 - PRNewsWire
- 1 day ago - Becton Dickinson price target raised to $195 from $165 at Barclays - TheFly
- 4 days ago - Becton Dickinson price target raised to $225 from $200 at BofA - TheFly
- 5 days ago - Becton Dickinson price target raised to $225 from $190 at RBC Capital - TheFly
- 5 days ago - Becton Dickinson price target raised to $220 from $188 at JPMorgan - TheFly
- 5 days ago - Becton Dickinson price target raised to $200 from $175 at Piper Sandler - TheFly
- 5 days ago - Becton Dickinson price target raised to $241 from $208 at Citi - TheFly
- 6 days ago - Becton Dickinson upgraded to Overweight from Equal Weight at Wells Fargo - TheFly